Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0001193125-21-036356
Filing Date
2021-02-10
Accepted
2021-02-10 16:37:00
Documents
2
Group Members
ALPHABET HOLDINGS LLCALPHABET INC.GV 2015 GP, L.L.C.XXVI HOLDINGS INC.

Document Format Files

Seq Description Document Type Size
1 SC 13G/A d122707dsc13ga.htm SC 13G/A 111048
2 EXHIBIT A d122707dex99a.htm EX-99.A 6903
  Complete submission text file 0001193125-21-036356.txt   119688
Mailing Address 675 MASSACHUSETTS AVENUE 14TH FLOOR CAMBRIDGE MA 02139
Business Address 675 MASSACHUSETTS AVENUE 14TH FLOOR CAMBRIDGE MA 02139 857-242-1600
Spero Therapeutics, Inc. (Subject) CIK: 0001701108 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-90168 | Film No.: 21614429
SIC: 2834 Pharmaceutical Preparations

Mailing Address 1600 AMPHITHEATRE PARKWAY MOUNTAIN VIEW CA 94043
Business Address 1600 AMPHITHEATRE PARKWAY MOUNTAIN VIEW CA 94043 650-335-5278
GV 2015, L.P. (Filed by) CIK: 0001719755 (see all company filings)

EIN.: 472144612 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A